Quality of Life for Patients with Sporadic Small Vestibular Schwannomas Following Middle Fossa Craniotomy

Abstract

Objective To evaluate quality-of-life outcomes for patients with vestibular schwannomas (VS) undergoing a middle cranial fossa (MCF) approach. Study Design Prospective study from 2018 to 2023. Setting Tertiary academic institution. Patients Adults with sporadic VS. Interventions MCF Main Outcome Measures The primary outcome measure was the change in preoperative and 1-year postoperative Penn Acoustic Neuroma Quality-of-life (PANQOL) scores. Secondary outcome measures included hearing preservation and facial nerve function. Results Of the 164 patients who underwent MCF for sporadic VS, 78 patients elected to voluntarily complete preoperative PANQOL assessments prior to surgery. Seventy-one (91%) of those 78 patients completed postoperative PANQOL surveys. Fifty (70%) of the respondents were female and the median age was 48 years (range, 27–71 years). Overall, at 1-year postsurgery, a minimal clinically important difference (MCID) was obtained in the hearing (mean difference, 10.5; 95% confidence interval [CI], 4.3–16.7) and anxiety (mean difference, 18.8; 95% CI, 11.7–25.9) domains. For patients with hearing preservation (n = 48, 68%), MCIDs were reached in the hearing (mean difference, 13.4; 95% CI, 6.3–20.6), anxiety (mean difference, 20.8; 95% CI, 11.8–29.9), energy (mean difference, 13.7; 95% CI, 3.6–23.8), pain (mean difference, 13.7; 95% CI, 3.6–23.8) domains, and overall PANQOL scores (mean difference, 12.7; 95% CI, 7.1–18.3). Postoperatively, 64 (90%) patients maintained a House-Brackmann I. Conclusions To our knowledge, this is the largest study examining disease-specific QOL for VS patients undergoing MCF. Based on our institution's experience, MCF approach for small VS is associated with clinically meaningful improvements in QOL, hearing preservation, and excellent facial nerve outcomes.